Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Introduction: The Gut-Brain Axis in Parkinson's Disease.

van Laar T.

J Parkinsons Dis. 2019;9(s2):S279. doi: 10.3233/JPD-199004. No abstract available.

PMID:
31683490
2.

Faecal Transplantation, Pro- and Prebiotics in Parkinson's Disease; Hope or Hype?

Van Laar T, Boertien JM, Herranz AH.

J Parkinsons Dis. 2019;9(s2):S371-S379. doi: 10.3233/JPD-191802.

PMID:
31609702
3.

rTMS treatment of visual hallucinations using a connectivity-based targeting method - A case study.

Invernizzi A, Halbertsma HN, van Ackooij M, Bais L, Boertien J, Renken RJ, Cornelissen FW, van Laar T.

Brain Stimul. 2019 Nov - Dec;12(6):1622-1624. doi: 10.1016/j.brs.2019.09.003. Epub 2019 Sep 13. No abstract available.

4.

Visual hallucinations in psychosis.

van Ommen MM, van Laar T, Cornelissen FW, Bruggeman R.

Psychiatry Res. 2019 Oct;280:112517. doi: 10.1016/j.psychres.2019.112517. Epub 2019 Aug 10.

PMID:
31446216
5.

[Deep brain stimulation for movement disorders].

Beudel M, Oterdoom DLM, van Egmond ME, van Laar T, de Koning-Tijssen MAJ, van Dijk JMC.

Ned Tijdschr Geneeskd. 2019 Aug 6;163. pii: D3758. Dutch.

PMID:
31386315
6.

[Parkinson's disease as a neuropsychiatric disorder].

Sommer IE, van Laar T.

Ned Tijdschr Geneeskd. 2019 Aug 6;163. pii: D4045. Dutch.

PMID:
31386313
7.

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease.

Bloem BR, Marks WJ Jr, Silva de Lima AL, Kuijf ML, van Laar T, Jacobs BPF, Verbeek MM, Helmich RC, van de Warrenburg BP, Evers LJW, intHout J, van de Zande T, Snyder TM, Kapur R, Meinders MJ.

BMC Neurol. 2019 Jul 17;19(1):160. doi: 10.1186/s12883-019-1394-3.

8.

Learning from Parkinson's patients: Usability of the Cyclops dry powder inhaler.

Luinstra M, Isufi V, de Jong L, Rutgers AWF, Hagedoorn P, Puttenstein J, van Laar T, Frijlink HW.

Int J Pharm. 2019 Aug 15;567:118493. doi: 10.1016/j.ijpharm.2019.118493. Epub 2019 Jul 3.

PMID:
31279054
9.

Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson's disease.

Luinstra M, Rutgers W, van Laar T, Grasmeijer F, Begeman A, Isufi V, Steenhuis L, Hagedoorn P, de Boer A, Frijlink HW.

Ther Adv Chronic Dis. 2019 Jun 21;10:2040622319857617. doi: 10.1177/2040622319857617. eCollection 2019.

10.

Parkinson's disease and long-term exposure to outdoor air pollution: A matched case-control study in the Netherlands.

Toro R, Downward GS, van der Mark M, Brouwer M, Huss A, Peters S, Hoek G, Nijssen P, Mulleners WM, Sas A, van Laar T, Kromhout H, Vermeulen R.

Environ Int. 2019 Aug;129:28-34. doi: 10.1016/j.envint.2019.04.069. Epub 2019 May 16.

11.

Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies.

Chrysou A, Jansonius NM, van Laar T.

Parkinsonism Relat Disord. 2019 Jul;64:40-49. doi: 10.1016/j.parkreldis.2019.04.023. Epub 2019 Apr 30. Review.

PMID:
31054866
12.

Direct comparison of oscillatory activity in the motor system of Parkinson's disease and dystonia: A review of the literature and meta-analysis.

Piña-Fuentes D, van Dijk JMC, Drost G, van Zijl JC, van Laar T, Tijssen MAJ, Beudel M.

Clin Neurophysiol. 2019 Jun;130(6):917-924. doi: 10.1016/j.clinph.2019.02.015. Epub 2019 Mar 15.

PMID:
30981177
13.

[18 F]Fluoroethoxybenzovesamicol in Parkinson's disease patients: Quantification of a novel cholinergic positron emission tomography tracer.

van der Zee S, Vállez García D, Elsinga PH, Willemsen ATM, Boersma HH, Gerritsen MJJ, Spikman JM, van Laar T.

Mov Disord. 2019 Jun;34(6):924-926. doi: 10.1002/mds.27698. Epub 2019 Apr 12. No abstract available.

PMID:
30977934
14.

Transcriptome Sequence of Antibiotic-Treated Pseudomonas aeruginosa.

Esani S, Chen T, Leung KP, Van Laar TA.

Microbiol Resour Announc. 2019 Mar 21;8(12). pii: e01367-18. doi: 10.1128/MRA.01367-18.

15.

Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.

Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA; LEAP Study Group.

N Engl J Med. 2019 Jan 24;380(4):315-324. doi: 10.1056/NEJMoa1809983.

PMID:
30673543
16.

Accuracy of Intraoperative Computed Tomography in Deep Brain Stimulation-A Prospective Noninferiority Study.

Kremer NI, Oterdoom DLM, van Laar PJ, Piña-Fuentes D, van Laar T, Drost G, van Hulzen ALJ, van Dijk JMC.

Neuromodulation. 2019 Jun;22(4):472-477. doi: 10.1111/ner.12918. Epub 2019 Jan 10.

17.

Borrelia parkeri in Ornithodoros parkeri (Ixodida: Argasidae) Collected Using Compact Dry Ice Traps in Madera County, California.

Osborne CJ, Crosbie PR, Van Laar TA.

J Med Entomol. 2019 Feb 25;56(2):579-583. doi: 10.1093/jme/tjy213.

PMID:
30517684
18.

Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases.

Borgemeester RWK, van Laar T, Schuttelaar MLA.

Contact Dermatitis. 2018 Nov;79(5):316-318. doi: 10.1111/cod.13058. Epub 2018 Aug 19. No abstract available.

PMID:
30123968
19.

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A.

Lancet Neurol. 2018 Sep;17(9):749-759. doi: 10.1016/S1474-4422(18)30239-4. Epub 2018 Jul 25.

PMID:
30055903
20.

Successful treatment of intractable visual hallucinations with 5-HT 2A antagonist ketanserin.

Sommer IEC, Kleijer H, Visser L, van Laar T.

BMJ Case Rep. 2018 Jun 27;2018. pii: bcr-2018-224340. doi: 10.1136/bcr-2018-224340.

PMID:
29950360
21.

Pseudomonas aeruginosa gshA Mutant Is Defective in Biofilm Formation, Swarming, and Pyocyanin Production.

Van Laar TA, Esani S, Birges TJ, Hazen B, Thomas JM, Rawat M.

mSphere. 2018 Apr 18;3(2). pii: e00155-18. doi: 10.1128/mSphere.00155-18. Print 2018 Apr 25.

22.

Oscillatory activity and cortical coherence of the nucleus basalis of Meynert in Parkinson's disease dementia.

Nazmuddin M, Oterdoom DLM, van Dijk JMC, van Zijl JC, Kampman AK, Drost G, van Laar T, Beudel M.

Parkinsonism Relat Disord. 2018 Jul;52:102-106. doi: 10.1016/j.parkreldis.2018.03.024. Epub 2018 Mar 28.

PMID:
29665982
23.

Effectiveness of ReSET; a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease.

Vlagsma TT, Duits AA, Dijkstra HT, van Laar T, Spikman JM.

Neuropsychol Rehabil. 2018 Mar 22:1-18. doi: 10.1080/09602011.2018.1452761. [Epub ahead of print]

PMID:
29566588
24.

Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.

van der Zee S, Vermeiren Y, Fransen E, Van Dam D, Aerts T, Gerritsen MJ, Spikman JM, van Laar T, De Deyn PP.

J Parkinsons Dis. 2018;8(1):71-84. doi: 10.3233/JPD-171228.

PMID:
29480224
25.

Effect of Pharmacist-Led Interventions on (Non)Motor Symptoms, Medication-Related Problems, and Quality of Life in Parkinson Disease Patients: A Pilot Study.

Stuijt C, Karapinar-Çarkit F, van den Bemt B, van Laar T.

Clin Neuropharmacol. 2018 Jan/Feb;41(1):14-19. doi: 10.1097/WNF.0000000000000260.

PMID:
29300205
26.

Deep Brain Stimulation for Essential Tremor: A Comparison of Targets.

Holslag JAH, Neef N, Beudel M, Drost G, Oterdoom DLM, Kremer NI, van Laar T, van Dijk JMC.

World Neurosurg. 2018 Feb;110:e580-e584. doi: 10.1016/j.wneu.2017.11.064. Epub 2017 Nov 28.

PMID:
29196249
27.

Substituting the Target After Unsatisfactory Outcome of Deep Brain Stimulation in Advanced Parkinson's Disease: Cases From the NSTAPS Trial and Systematic Review of the Literature.

Ten Brinke TR, Odekerken VJJ, van Laar T, van Dijk JMC, Dijk JM, van den Munckhof P, Schuurman PR, de Bie RMA.

Neuromodulation. 2018 Aug;21(6):527-531. doi: 10.1111/ner.12732. Epub 2017 Nov 22.

PMID:
29164735
28.

Signatures of Nucleotide Analog Incorporation by an RNA-Dependent RNA Polymerase Revealed Using High-Throughput Magnetic Tweezers.

Dulin D, Arnold JJ, van Laar T, Oh HS, Lee C, Perkins AL, Harki DA, Depken M, Cameron CE, Dekker NH.

Cell Rep. 2017 Oct 24;21(4):1063-1076. doi: 10.1016/j.celrep.2017.10.005.

29.

Analysis of DNA and RNA Binding Properties of Borrelia burgdorferi Regulatory Proteins.

Seshu J, Smith TC 2nd, Lin YH, Karna SLR, Miller CL, Van Laar T.

Methods Mol Biol. 2018;1690:155-175. doi: 10.1007/978-1-4939-7383-5_13.

PMID:
29032544
30.

Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study.

Borgemeester RWK, van Laar T.

Parkinsonism Relat Disord. 2017 Dec;45:33-38. doi: 10.1016/j.parkreldis.2017.09.025. Epub 2017 Sep 29.

PMID:
29032012
31.

A Guideline for Parkinson's Disease Nurse Specialists, with Recommendations for Clinical Practice.

Lennaerts H, Groot M, Rood B, Gilissen K, Tulp H, van Wensen E, Munneke M, van Laar T, Bloem BR.

J Parkinsons Dis. 2017;7(4):749-754. doi: 10.3233/JPD-171195. Review.

PMID:
28800338
32.

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.

Meles SK, Vadasz D, Renken RJ, Sittig-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, Kesper K, Adriaanse SM, Booij J, Leenders KL, Oertel WH.

Mov Disord. 2017 Oct;32(10):1482-1486. doi: 10.1002/mds.27094. Epub 2017 Jul 22.

33.

Environmental exposure to pesticides and the risk of Parkinson's disease in the Netherlands.

Brouwer M, Huss A, van der Mark M, Nijssen PCG, Mulleners WM, Sas AMG, van Laar T, de Snoo GR, Kromhout H, Vermeulen RCH.

Environ Int. 2017 Oct;107:100-110. doi: 10.1016/j.envint.2017.07.001. Epub 2017 Jul 10.

PMID:
28704700
34.

Adaptive DBS in a Parkinson's patient with chronically implanted DBS: A proof of principle.

Piña-Fuentes D, Little S, Oterdoom M, Neal S, Pogosyan A, Tijssen MAJ, van Laar T, Brown P, van Dijk JMC, Beudel M.

Mov Disord. 2017 Aug;32(8):1253-1254. doi: 10.1002/mds.26959. Epub 2017 Jun 7. No abstract available.

35.

Objective Versus Subjective Measures of Executive Functions: Predictors of Participation and Quality of Life in Parkinson Disease?

Vlagsma TT, Koerts J, Tucha O, Dijkstra HT, Duits AA, van Laar T, Spikman JM.

Arch Phys Med Rehabil. 2017 Nov;98(11):2181-2187. doi: 10.1016/j.apmr.2017.03.016. Epub 2017 Apr 17.

PMID:
28427928
36.

Draft Genome Sequence of a Multidrug-Resistant Strain of Enterococcus faecalis, PM01, Isolated from the Nest of an American Bushtit, Psaltriparius minimus.

Esani S, Constable JV, Van Laar TA.

Genome Announc. 2017 Mar 16;5(11). pii: e00017-17. doi: 10.1128/genomeA.00017-17.

37.

The role and structure of the multidisciplinary team in the management of advanced Parkinson's disease with a focus on the use of levodopa-carbidopa intestinal gel.

Pedersen SW, Suedmeyer M, Liu LW, Domagk D, Forbes A, Bergmann L, Onuk K, Yegin A, van Laar T.

J Multidiscip Healthc. 2017 Jan 4;10:13-27. doi: 10.2147/JMDH.S111369. eCollection 2017. Review.

38.

Spermine and Spermidine Alter Gene Expression and Antigenic Profile of Borrelia burgdorferi.

Lin YH, Romo JA, Smith TC 2nd, Reyes AN, Karna SLR, Miller CL, Van Laar TA, Yendapally R, Chambers JP, Seshu J.

Infect Immun. 2017 Feb 23;85(3). pii: e00684-16. doi: 10.1128/IAI.00684-16. Print 2017 Mar.

39.

The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine.

van Laar T, Borgemeester R.

Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S22-S27. doi: 10.1016/j.parkreldis.2016.11.019. Epub 2016 Dec 18. Review.

PMID:
27998652
40.

Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy.

Bhidayasiri R, Boonpang K, Jitkritsadakul O, Calne SM, Henriksen T, Trump S, Chaiwong S, Susang P, Boonrod N, Sringean J, van Laar T, Drent M, Chaudhuri KR.

Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S49-S55. doi: 10.1016/j.parkreldis.2016.11.014. Epub 2016 Dec 9. Review.

PMID:
27939324
41.

Unmet needs in Parkinson's disease: New horizons in a changing landscape.

Chaudhuri KR, Bhidayasiri R, van Laar T.

Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S2-S8. doi: 10.1016/j.parkreldis.2016.11.018. Epub 2016 Dec 6. Review.

PMID:
27932224
42.

Global transcriptome responses including small RNAs during mixed-species interactions with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Miller CL, Van Laar TA, Chen T, Karna SLR, Chen P, You T, Leung KP.

Microbiologyopen. 2017 Jun;6(3). doi: 10.1002/mbo3.427. Epub 2016 Nov 21.

43.

Genome Sequences of Three Spore-Forming Bacteria Isolated from the Feces of Organically Raised Chickens.

Kennedy V, Van Laar TA, Aleru O, Thomas M, Ganci M, Rawat M.

Genome Announc. 2016 Sep 1;4(5). pii: e00880-16. doi: 10.1128/genomeA.00880-16.

44.

Genome Sequence of a Multidrug-Resistant Strain of Bacillus pumilus, CB01, Isolated from the Feces of an American Crow, Corvus brachyrhynchos.

Nelson RL, Castro MA, Katti M, Eisen JA, Van Laar TA.

Genome Announc. 2016 Aug 18;4(4). pii: e00807-16. doi: 10.1128/genomeA.00807-16.

45.

How typical are 'typical' tremor characteristics? Sensitivity and specificity of five tremor phenomena.

van der Stouwe AM, Elting JW, van der Hoeven JH, van Laar T, Leenders KL, Maurits NM, Tijssen MA.

Parkinsonism Relat Disord. 2016 Sep;30:23-8. doi: 10.1016/j.parkreldis.2016.06.008. Epub 2016 Jun 16.

PMID:
27346607
46.

Mental slowness in patients with Parkinson's disease: Associations with cognitive functions?

Vlagsma TT, Koerts J, Tucha O, Dijkstra HT, Duits AA, van Laar T, Spikman JM.

J Clin Exp Neuropsychol. 2016 Oct;38(8):844-52. doi: 10.1080/13803395.2016.1167840. Epub 2016 May 1.

PMID:
27132647
47.

Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence.

Borgemeester RW, Lees AJ, van Laar T.

Parkinsonism Relat Disord. 2016 Jun;27:35-40. doi: 10.1016/j.parkreldis.2016.04.023. Epub 2016 Apr 22. Review.

PMID:
27132157
48.

A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity.

Heetla HW, Proost JH, Molmans BH, Staal MJ, van Laar T.

Br J Clin Pharmacol. 2016 Jan;81(1):101-12.

49.

High-throughput, high-force probing of DNA-protein interactions with magnetic tweezers.

Berghuis BA, Köber M, van Laar T, Dekker NH.

Methods. 2016 Aug 1;105:90-8. doi: 10.1016/j.ymeth.2016.03.025. Epub 2016 Mar 30.

50.

Statins reduce spirochetal burden and modulate immune responses in the C3H/HeN mouse model of Lyme disease.

Van Laar TA, Hole C, Rajasekhar Karna SL, Miller CL, Reddick R, Wormley FL, Seshu J.

Microbes Infect. 2016 Jun;18(6):430-435. doi: 10.1016/j.micinf.2016.03.004. Epub 2016 Mar 16.

Supplemental Content

Loading ...
Support Center